Celgene Corporation

CELG 
(NASDAQ) 
 
$ 93.47 <%= Resources.Global.txtDown %>
Updated 23/06/2019
Change % -5.50% Stock price decreasing
Change -5.44 Stock price decreasing
Volume 6,112,051
High $ 95.77
Low $ 93.47
Open $ 95.63
ISIN
Prev close $ 98.91
# of shares 705.26M
Market cap 65,921M USD
Intraday

Market closed
Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  93.47 -3.8% Stock price decreasing -1.9% Stock price decreasing 6.3% Stock price increasing 57.9% Stock price increasing 19.0% Stock price increasing
Powered by TradingView

News about Celgene Corporation

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Bristol-Myers Squibb Company 45.68 -4.4% Stock price decreasing -2.4% Stock price decreasing -3.8% Stock price decreasing -6.3% Stock price decreasing -16.4% Stock price decreasing -12.1% Stock price decreasing
 
Johnson & Johnson 143.06 2.0% Stock price increasing 3.0% Stock price increasing 4.7% Stock price increasing 16.5% Stock price increasing 16.7% Stock price increasing 10.9% Stock price increasing
 
Merck & Company Inc (new) 85.51 1.2% Stock price increasing 5.3% Stock price increasing 3.8% Stock price increasing 20.2% Stock price increasing 39.1% Stock price increasing 11.9% Stock price increasing
 
Pfizer Inc 43.76 1.6% Stock price increasing 4.3% Stock price increasing 4.5% Stock price increasing 7.9% Stock price increasing 20.3% Stock price increasing 0.3% Stock price increasing
 
Amgen Inc 184.83 1.8% Stock price increasing 7.9% Stock price increasing -0.9% Stock price decreasing 3.6% Stock price increasing -0.3% Stock price decreasing -5.1% Stock price decreasing
 
Gilead Sciences Inc 68.84 0.9% Stock price increasing 2.9% Stock price increasing 7.9% Stock price increasing 13.7% Stock price increasing -3.2% Stock price decreasing 10.1% Stock price increasing
 
Vertex Pharmaceuticals Incorpo.. 181.02 1.7% Stock price increasing 5.4% Stock price increasing -1.5% Stock price decreasing 19.2% Stock price increasing 17.0% Stock price increasing 9.2% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,438.00 0.4% Stock price increasing 5.7% Stock price increasing 1.0% Stock price increasing 8.0% Stock price increasing 23.8% Stock price increasing 9.6% Stock price increasing
 
Novartis AG 92.80 1.6% Stock price increasing 6.0% Stock price increasing -0.5% Stock price decreasing 12.5% Stock price increasing 25.4% Stock price increasing 8.1% Stock price increasing
 
Takeda PHARM.CO.LTD. 30.30 -0.7% Stock price decreasing -4.6% Stock price decreasing -17.7% Stock price decreasing 2.1% Stock price increasing -13.2% Stock price decreasing 4.7% Stock price increasing
 
Biogen Inc 235.91 1.2% Stock price increasing 3.9% Stock price increasing 7.1% Stock price increasing -15.3% Stock price decreasing -19.3% Stock price decreasing -21.6% Stock price decreasing
 
Roche Hldg Sp.Adr 1/8 30.99 1.0% Stock price increasing 3.3% Stock price increasing 5.2% Stock price increasing 18.2% Stock price increasing 33.0% Stock price increasing 20.0% Stock price increasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Bristol-Myer.. 45.68 -7.4% Stock price decreasing
Johnson & Jo.. 143.06 0.7% Stock price increasing
Merck & Comp.. 85.51 1.1% Stock price increasing
Pfizer Inc 43.76 0.2% Stock price increasing
Amgen Inc 184.83 -1.2% Stock price decreasing
100,60,52,56,61,44,38,33,21,0
Gilead Scien.. 68.84 -0.8% Stock price decreasing
100,100,100,49,49,49,0,0,0,0
Vertex Pharm.. 181.02 -1.6% Stock price decreasing
Astrazeneca .. 6,438.00 0.9% Stock price increasing
Novartis AG 92.80 0.3% Stock price increasing
Takeda PHARM.. 30.30 -0.8% Stock price decreasing
0,0,100,100,100,0,0,0,0,0
Biogen Inc 235.91 -1.3% Stock price decreasing
Roche Hldg S.. 30.99 -0.8% Stock price decreasing
0,0,0,0,0,0,0,0,0,0

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 June 2019 03:31:36
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 04:31:36 - 2019-06-25 03:31:36 - 1000 - Website: OKAY